Cantargia, Capital Markets Day, 2021
May 20th 2021 15:00 (Europe/Stockholm)Language:
English
Speaker:
CEO, Göran Forsberg. VP Research, David Liberg. CMO, Ignacio Garcia-Ribas. Ahmad Awada, Professor at Institut Jules Bordet and Manuel Hidalgo Medina, M.D. Ph.D. Chief of the Division of Hematology and Medical Oncology at Weill Cornell Medicine.
Sector:
Health care - Pharmaceuticals & Biotechnology
Listing:
Small Cap
Activity:
Capital Markets Day
- 15.00 Welcome and introduction to Cantargia – Göran Forsberg, CEO Cantargia
- 15.05 Nadunolimab (CAN04) Mechanism of action – David Liberg, VP Research Cantargia
- 15.25 Nadunolimab updated phase IIa clinical results in pancreatic cancer – Prof Ahmad Awada, Inst. Jules Bordet, Brussels, Belgium
- 15.50 Pancreatic cancer and context for nadunolimab results – Dr Manuel Hidalgo, Weill-Cornell, New York
- 16.10 Nadunolimab current and upcoming clinical trials, Ignacio Garcia-Ribas, CMO Cantargia
- 16.25 CAN10 project and new preclinical results– David Liberg, VP Research Cantargia
- 16.45 Q&A (Alla deltar)
- 17.00 End of presentation – Göran Forsberg, CEO Cantargia